Efficient Synthesis and in Silico Studies of the Benzimidazole Hybrid Scaffold with the Quinolinyloxadiazole Skeleton with Potential α‑Glucosidase Inhibitory, Anticoagulant, and Antiplatelet Activities for Type-II Diabetes Mellitus Management and Treating Thrombotic Disorders

Efficient Synthesis and in Silico Studies of the Benzimidazole Hybrid Scaffold with the Quinolinyloxadiazole Skeleton with Potential α‑Glucosidase Inhibitory, Anticoagulant, and Antiplatelet Activities for Type-II Diabetes Mellitus Management and Treating Thrombotic Disorders

Bibliographic Details
Main Authors: S. Shashidhar Bharadwaj, Boja Poojary, Sharath Kumar M. Nandish, Jayanna Kengaiah, Mugaranja P. Kirana, Madan Kumar Shankar, Anupam J. Das, Ananda Kulal, Devaraja Sannaningaiah
Format: Article
Language:English
Published: American Chemical Society 2018-10-01
Series:ACS Omega
Online Access:http://dx.doi.org/10.1021/acsomega.8b01476

Internet

http://dx.doi.org/10.1021/acsomega.8b01476

Similar Items